Advertisement
Cumulative reductions in federal payments to hospitals from 2010 to 2028 are estimated to reach $218.2 billion

Hospitals Face $218B in Federal Payment Cuts From 2010 to 2028

0
11 pieces of legislation plus regulatory changes result in payment reductions beyond those under ACA
For patients with hereditary transthyretin amyloidosis with polyneuropathy

Patisiran, Inotersen Aid Hereditary Transthyretin Amyloidosis

0
Improvement in modified Neuropathy Impairment Score+7, Norfolk QoL Diabetic Nephropathy score
In 2013

1996 to 2013 Saw Large Increase in Diabetes Spending

0
Increased spending per encounter has been the biggest driver of overall rise in spending
Anticonvulsant drugs are ineffective for chronic low back pain and can cause harm

Anticonvulsants Seem to Be Ineffective for Low Back Pain

0
And, gabapentinoids have a higher risk for adverse events
For women after vaginal birth

For Postpartum Hemorrhage, Carbetocin Similar to Oxytocin

0
Heat-stable carbetocin non-inferior for preventing blood loss of ≥500 ml, use of other uterotonic agents
An oral insulin formulation has been developed using choline and geranate ionic liquid

Oral Insulin Choline, Geranate Ionic Liquid Shows Promise

0
Significant, sustained decrease in blood glucose levels with low insulin doses of 3 to 10 U/kg

June 2018 Briefing – Pharmacy

0
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for June 2018. This roundup includes the latest...
For patients with advanced chronic obstructive pulmonary disease

Use of Palliative Care, Oxygen Therapy Increasing for COPD

0
Increase in use of formal palliative care services, long-term oxygen, but proportions still remain low
For high-risk patients

Intensive Management Program Benefits High-Risk Patients

0
Access to intensive management program results in more outpatient care with no increase in total costs
Approval of the MiniMed 670G hybrid closed looped system for diabetes management has been expanded to include individuals aged 7 to 13 years with type 1 diabetes

FDA Expands Approval of Closed-Looped Insulin Delivery System

0
MiniMed 670G automated insulin delivery system deemed safe for children 7 to 13 with type 1 diabetes